Coronary stenting in cardiac allograft vasculopathy

Journal of the American College of Cardiology

Volumn 32, Issue 6, 1998, Pages 1636-1640

  Jain, Suresh P ^a   Ramee, Stephen R ^a   White, Christopher J ^a   Mehra, Mandeep R ^a   Ventura, Hector O ^a   Zhang, Shuyang ^a   Jenkins, J Stephen ^a   Collins, Tyrone J ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FEMALE; GRAFT SURVIVAL; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HUMAN; MALE; PRIORITY JOURNAL; STENT; TREATMENT OUTCOME;

CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; STENTS;

EID: 0032533245     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00432-X     Document Type: Article

References (22)

1. Bieber CP, Hunt SA, Schwinn DA, et al. Complications in long-term survivors of cardiac transplantation. Transplant Proc 1981;8:207-11.
2. Hunt SA, Billingham M. Long-term results of cardiac transplantation. Annu Rev Med 1991;42:437-47.
3. Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987;76:827-33.
4. Keogh AM, Valentine HA, Hunt SA, et al. Impact of proximal or mid-vessel discrete coronary artery stenosis on survival after heart transplantation. J Heart Lung Transplant 1992;11:892-901.
5. Mehra MR, Ventura HO, Stapleton DD, Smart FFW, Collins TC, Ramee SR. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy. J Heart Lung Transplant 1995;14:632-9.
6. Gao SZ, Schroeder JS, Hunt S, Stinson EB. Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol 1988;62:876-81.
7. Schroeder JS, Gao SZ, Alderman EA, et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart transplant recipients. N Engl J Med 1993;328:164-70.
8. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995;333:621-7.
9. Wenke K, Meiser B, Thiery J, et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation. A four year randomized study. Circulation 1997;96:1398-402.
10. Sandhu JS, Uretsky BF, Reddy S, et al. Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients. Am J Cardiol 1992;69:1234-7.
11. Swan JW, Norell M, Yacoub M, Mitchell G, Ilsley C. Coronary angioplasty in cardiac transplant recipients. Eur Heart J 1993;14:65-70.
12. Halle AA, DiSciascio G, Marsin EK, et al. Coronary angioplasty, atherectomy, and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 1995;26:120-8.
13. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
14. Savage MP, Fischman DL, Schatz RA, et al. Long-term angiographic and clinical outcome after implantation of a balloon expandable stent in the native coronary artery circulation. J Am Coll Cardiol 1994;24:1207-12.
15. Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant recipient: coronary angiographic findings. J Am Coll Cardiol 1988;12:334-40.
16. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1992;11:S38-S44.
17. Johnson DE, Alderman EL, Schroeder JS, et al. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol 1991;17:449-57.
18. Mehra MR, Ventura HO, Jain SP, et al. Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy. J Am Coll Cardiol 1997;29:1339-44.
19. Cusick D, Davidson C, Frolich T, Davis G, Salinger M. Coronary stenting postcardiac transplant: a report of two cases. Cathet Cardiovasc Diagn 1997;40:92-6.
20. Chakrabarti R, Engleman EG. Interrelationships between mevalonate metabolism and the mitogenic signalling pathway in T lymphocyte proliferation. J Biol Chem 1991;266:1216-22.
21. Vincent TS, Wulfert E, Merler E. Inhibition of growth factors signaling by lovastatin. Biochem Biophys Res Commun 1991;180:1284-9.
22. Glomset JA, Gelb MH, Farnsworth CC. Geranylgeranylated proteins. Biochem Soc Trans 1992;20:479-84.